Czechia, Dec. 30 -- Czechia based Bristol-Myers Squibb spol. s r.o. has secured contract from Fakultni nemocnice Olomouc for Cardiac therapy medicinal products - LP s obsahem mavakamtenu 2025. The value of the contract is worth 1912139835 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....